Considering the importance of anti-gp210 antibodies in diagnosis and prognosis of PBC, our results strongly suggest that additional ELISA kits should be developed including the N-terminal epitope as substrate and various secondary reagents for the identification of anti-gp210 autoantibodies of all specificities and Ig class. This evidence concerns the gene NUP210 and primary biliary cholangitis.